【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Causes of H1N1 diseases
• Signs and symptoms
PART 06: Regulatory scenario of vaccines
PART 07: WHO recommendations for H1N1 vaccines
• Key H1N1 virus vaccines for 2014-2015 season in US
• H1N1 virus vaccines approved in EU
PART 08: Reimbursement for influenza vaccines in US
• The US healthcare reform
• Reimbursement for influenza vaccines
PART 09: Reimbursement for influenza vaccines in other major countries
• UK
• Germany
• Spain
• Italy
• France
• Japan
PART 10: Market landscape
• Global human vaccines market
• Global H1N1 vaccines market
• Five forces analysis
PART 11: Market segmentation by ROA
• Intramuscular vaccines
• Intranasal vaccines
• Intradermal vaccines
PART 12: Geographical segmentation
• Global H1N1 vaccines market by geographical segmentation 2015-2020
• H1N1 vaccines market in Americas
• H1N1 vaccines market in EMEA
• H1N1 vaccines market in APAC
PART 13: Market drivers
• Global action plan for influenza vaccines
• Increase in R&D
• Inclusion in NIP
• Rise in awareness
PART 14: Impact of drivers
PART 15: Market challenges
• Antigenic drift and shift of H1N1v virus
• Vaccine storage and handling issues
• Stringent regulatory guidelines
• Emergence of local players
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Universal influenza vaccine
• Emergence of quadrivalent vaccines
• Increase in strategic alliances and M&A
• Improved understanding of immunology
PART 18: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Sanofi
• GSK
• AstraZeneca
• CSL
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for H1N1 vaccines
Exhibit 03: Pediatric influenza vaccine price list 2015
Exhibit 04: Adult influenza vaccine price list 2015
Exhibit 05: Requirements for a BLA submission
Exhibit 06: Different types of development necessary to reach the vaccine licensing stage
Exhibit 07: Typical vaccine development process (over a period of up to 15 years and at a cost of up to $1 billion)
Exhibit 08: Regulatory testing of licensed vaccines
Exhibit 09: Comparison of US healthcare system before and after reforms
Exhibit 10: Coding options for diagnosis of influenza vaccines
Exhibit 11: Medicare (Part B) current procedural terminology (CPT) codes for influenza vaccines
Exhibit 12: Top 10 pharmaceutical companies based on global vaccines market revenues 2015 ($ billions)
Exhibit 13: Global human vaccines market 2015-2020 ($ billions)
Exhibit 14: Market share of H1N1 vaccines markets in global human vaccines market 2015
Exhibit 15: Global H1N1 vaccines market 2015-2020 ($ billions)
Exhibit 16: Five forces analysis
Exhibit 17: Global H1N1 vaccines market segmentation by ROA
Exhibit 18: Global H1N1 vaccines market segmentation by ROA 2015
Exhibit 19: Global H1N1 vaccines market by geography 2015
Exhibit 20: Global H1N1 vaccines market by geography 2020
Exhibit 21: Global H1N1 vaccines market revenue by geography 2015-2020 ($ billions)
Exhibit 22: Percentage share of H1N1 vaccines market by geography 2015-2020
Exhibit 23: Global H1N1 vaccines market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 24: H1N1 vaccines market in Americas 2015-2020 ($ billions)
Exhibit 25: H1N1 vaccines market in EMEA 2015-2020 ($ millions)
Exhibit 26: H1N1 vaccines market in APAC 2015-2020 ($ millions)
Exhibit 27: A few pipeline molecules for H1N1 vaccines
Exhibit 28: Impact of drivers
Exhibit 29: A typical cold chain process
Exhibit 30: Impact of drivers and challenges
Exhibit 31: Overview of major H1N1 vaccine-related acquisitions 2005-2012)
Exhibit 32: Market share analysis of global H1N1 vaccines market 2015
Exhibit 33: Sanofi: YoY revenue growth of influenza vaccines 2013-2015 ($ billions)
Exhibit 34: Sanofi: Geographic segmentation of influenza vaccines 2015
Exhibit 35: Sanofi: Key takeaways
Exhibit 36: GSK: YoY revenue and growth rate of Fluarix and FluLaval 2013-2015 ($ millions)
Exhibit 37: GSK: Geographical segmentation of Fluarix and FluLaval 2015
Exhibit 38: GSK: Key takeaways
Exhibit 39: AstraZeneca: YoY revenue and growth rate of Fluenz 2013-2015 ($ millions)
Exhibit 40: AstraZeneca: Geographical segmentation of Fluenz 2015 ($ millions)
Exhibit 41: AstraZeneca: Key takeaways
Exhibit 42: CSL: YoY revenue and growth rate of influenza vaccines 2013-2015 ($ millions)
Exhibit 43: CSL: Key takeaways
【レポート販売概要】
■ タイトル:H1N1(新型インフルエンザA)ワクチンの世界市場2016-2020■ 英文:Global H1N1 Vaccines Market 2016-2020
■ 発行日:2016年6月3日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9538
■ 調査対象地域:グローバル
- 予測分析アプリケーションの世界市場予測(~2020)The predictive analytics market size is expected to grow from USD 2.74 Billion in 2015 to USD 9.20 Billion by 2020, at an estimated Compound Annual Growth Rate (CAGR) of 27.4% during the forecast period. Increase in the amount of structured and unstructured data is the foremost factor that is driving the need of this market. Also, increased focus on market and competitive intelligence, transformat …
- Resaca Exploitation, Inc.:石油・ガスの開発・生産動向及びコスト分析– 2012Resaca Exploitation, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Resaca Exploitation, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- シングルユースバイオリアクターの世界市場予測(~2021年):幹細胞、インターフェロン、モノクローナル抗体、ワクチン、組み換えタンパク質、遺伝子改変型細胞The global single-use bioreactor (SUBs) market is projected to reach USD 1,085.7 Million by 2021 from USD 408.4 Million in 2016, growing at a CAGR of 21.6% during the forecast period of 2016 to 2021. Improved return on investment for small companies and startups, reduced complexity in automation, requirement of low capital investments, and lower environmental impact of operations using SUBs are th …
- 獣医用CROの世界市場:タイプ別(臨床試験、毒性学、市場認可&規制サポート、その他)、用途別(犬、猫、その他)、エンドユーザー別(腫瘍学、感染症、神経学、その他)The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026. Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor comp …
- ラグジュアリーセグメント用自動運転車の世界市場予測(~2030年)“Increasing demand for luxury vehicles is set to drive the autonomous vehicle market for luxury segment”The global autonomous vehicle market for luxury segment is projected to be 27,906 units in 2025 and is projected to grow to 126,774 units by 2030, at a CAGR of 35.35%. Increasing accident fatalities coupled with rising concern for vehicle safety and security have accentuated the need for the dev …
- Traverse Energy Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Traverse Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Traverse Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 世界の女性用インティメートケア製品市場:流通経路別、地域別Global Women’s Intimate Care Products: About this market Technavio’s women’s intimate care products market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of women’s intimate care products in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend is expected to cont …
- 世界の定量ポンプ市場調査:Global Metering Pump Market 2014-2018TechNavio's analysts forecast the Global Metering Pump market to grow at a CAGR of 4.04 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for safe drinking water. The Global Metering Pump market has also been witnessing the increasing popularity of digital pumping solutions. However, the increasing price wars among vendors could p …
- 直流電源システムの世界市場2017-2021About DC Power System The DC power systems are broadly categorized into DC-DC and AC-DC power supply. Such systems are mainly used in telecom towers, data centers, industrial loads, commercial buildings, residential loads, electronics appliances, automotive, medical equipment, and aircraft. The system uses semiconductor switches such as diode and thyristors for the conversion process. Since the gl …
- 予防医療技術とサービスの世界市場の規模および予測:技術別(早期発見とスクリーニング、ワクチン、慢性疾患管理、先進技術によるエラー削減)、セグメント予測、2013-2024The global preventive healthcare technologies and services market is expected to reach USD 432.4 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending. The growth of this market is attributed t …
- ペン針の世界市場分析:製品別(標準的なペン針、安全ペン針)、針の長さ別(4mm、5mm、6mm、8mm、10mm、12mm)、治療別(インスリン、グルカゴン様ペプチド-1 [GLP-1]、成長ホルモン)、セグメント予測、2014-2025The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes …
- 世界主要先進国における救命・集中治療市場(~2020)Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides …
- 炭素繊維プリプレグの世界市場予測(~2021年)“The carbon fiber prepreg market is projected to grow at a CAGR of 11.0% during the forecast period, 2016 to 2021.”The carbon fiber prepreg market is projected to reach USD 7.20 billion by 2021, at a CAGR of 11.0% between 2016 and 2021. The major drivers fueling the growth of the carbon fiber prepreg market are increasing demand for fuel efficient vehicles, growing use of carbon fiber prepregs in …
- 検尿の世界市場分析:製品別(機器、消耗品)、用途別(尿路感染症、糖尿病、腎疾患、高血圧、肝臓病)、エンドユーザー別(病院、診療所、在宅医療、研究、学術研究)、セグメント予測Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable …
- 医薬品膜ろ過の世界市場予測(~2021):製品別(MCE、加工酢酸セルロース、ナイロン、PVDF膜)、技術別(精密ろ過、超ろ過、ナノろ過)、用途別(最終製品、原材料)The global pharmaceutical membrane filtration market is expected to reach USD 6.20 billion by 2021 from USD 3.55 billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the market. On the other hand, strict government regulations for validation of the filtration proce …